RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fate Therapeutics - Stock

Fate Therapeutics Net Income 2024

Fate Therapeutics Net Income

-220.36 M USD

Ticker

FATE

ISIN

US31189P1021

WKN

A1W50M

In 2024, Fate Therapeutics's profit amounted to -220.36 M USD, a 36.93% increase from the -160.93 M USD profit recorded in the previous year.

The Fate Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-

Fate Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fate Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fate Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fate Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fate Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fate Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fate Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fate Therapeutics’s growth potential.

Fate Therapeutics Revenue, Profit, and EBIT History

DateFate Therapeutics RevenueFate Therapeutics EBITFate Therapeutics Net Income
2029e229.91 M undefined0 undefined-34.83 M undefined
2028e89.96 M undefined-226.95 M undefined-104.5 M undefined
2027e16.18 M undefined-267.71 M undefined-122.49 M undefined
2026e4.86 M undefined-252.73 M undefined-181.21 M undefined
2025e3.45 M undefined-240.73 M undefined-214.96 M undefined
2024e4.72 M undefined-215.3 M undefined-220.36 M undefined
202363.53 M undefined-190.51 M undefined-160.93 M undefined
202296.3 M undefined-308.39 M undefined-281.72 M undefined
202155.85 M undefined-216.99 M undefined-212.15 M undefined
202031.43 M undefined-128.09 M undefined-173.39 M undefined
201910.68 M undefined-100.73 M undefined-98.15 M undefined
20184.74 M undefined-67.09 M undefined-66.6 M undefined
20174.11 M undefined-42.12 M undefined-42.95 M undefined
20164.4 M undefined-31.96 M undefined-33.46 M undefined
20152.43 M undefined-27.78 M undefined-29.99 M undefined
20140 undefined-24.91 M undefined-25.88 M undefined
2013970,000 undefined-17.68 M undefined-20.89 M undefined
20122.67 M undefined-13.56 M undefined-14.24 M undefined
20111.17 M undefined-13.19 M undefined-13.43 M undefined

Fate Therapeutics stock margins

The Fate Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fate Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fate Therapeutics.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fate Therapeutics's sales revenue. A higher gross margin percentage indicates that the Fate Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fate Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fate Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fate Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fate Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fate Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fate Therapeutics Margin History

Fate Therapeutics Gross marginFate Therapeutics Profit marginFate Therapeutics EBIT marginFate Therapeutics Profit margin
2029e0 %0 %-15.15 %
2028e0 %-252.27 %-116.15 %
2027e0 %-1,654.19 %-756.87 %
2026e0 %-5,205.61 %-3,732.41 %
2025e0 %-6,969.59 %-6,223.47 %
2024e0 %-4,557.62 %-4,664.76 %
20230 %-299.86 %-253.3 %
20220 %-320.24 %-292.54 %
20210 %-388.52 %-379.86 %
20200 %-407.54 %-551.67 %
20190 %-943.16 %-919.01 %
20180 %-1,415.4 %-1,405.06 %
20170 %-1,024.82 %-1,045.01 %
20160 %-726.36 %-760.45 %
20150 %-1,143.21 %-1,234.16 %
20140 %0 %0 %
20130 %-1,822.68 %-2,153.61 %
20120 %-507.87 %-533.33 %
20110 %-1,127.35 %-1,147.86 %

Fate Therapeutics Aktienanalyse

What does Fate Therapeutics do?

Fate Therapeutics Inc is a biotechnology company specializing in the development of cell therapies. The company was founded in 2007 by four scientists who recognized the need for new therapies and treatment options. Their goal was to find new ways to promote tissue and organ regeneration and repair by harnessing the biological mechanisms within cells. Fate Therapeutics' business model is to develop and market state-of-the-art cell therapies based on human stem cells. These stem cells are typically obtained from patients' bone marrow or adipose tissue and then cultured in specialized cell cultures to prepare them for medical use. Fate Therapeutics currently offers several different products and services, including: - Cell therapies for the treatment of cancer: The company has developed a range of cell therapies aimed at boosting the immune system and mobilizing against cancer cells. These therapies are based on the method of extracting so-called T cells from the patient's blood, growing and modifying them in the lab to enhance their ability to target cancer cells. - Therapies for the treatment of genetic diseases: Fate Therapeutics has also developed cell therapies aimed at treating genetic mutations or defects. These therapies are based on the method of obtaining pluripotent stem cells (iPS cells) from the patient's blood or adipose tissue and then differentiating them into specialized cell types that can be used to repair tissue damage or correct genetic defects. - Services to support research and development: Fate Therapeutics also offers services to assist researchers in developing and testing their own cell therapies. This includes the cell cultures, devices, and assays needed to generate and analyze new cell lines. Fate Therapeutics is divided into several divisions to better manage its various business areas. These divisions include: - Research & Development: This division is responsible for conducting basic research to develop and test new cell therapies. This includes both foundational research and the clinical trials necessary to evaluate the effectiveness and safety of new therapies. - Manufacturing: This division is responsible for the large-scale production and processing of Fate Therapeutics' cell therapies. The company has multiple production facilities in the United States and internationally to ensure swift and efficient manufacturing and delivery of its therapies. - Sales & Marketing: This division is responsible for marketing and selling Fate Therapeutics' cell therapies. The company works closely with doctors, clinics, and medical facilities to ensure that therapies reach the patients who need them. Overall, Fate Therapeutics has become a global leader in the development of cell therapies. The company has made significant progress in recent years in developing new therapies and continues to work on finding innovative solutions to medical challenges. With its competent leadership and top-notch products and services, Fate Therapeutics Inc. is poised for even greater success in the future. Fate Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Fate Therapeutics's Profit Margins

The profit margins of Fate Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Fate Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Fate Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Fate Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Fate Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Fate Therapeutics Stock

How much profit has Fate Therapeutics made this year?

Fate Therapeutics has made -220.36 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 36.93% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Fate Therapeutics publish its earnings?

Fate Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Fate Therapeutics?

The profits of Fate Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Fate Therapeutics?

You can learn more about the earnings of Fate Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Fate Therapeutics pay?

Over the past 12 months, Fate Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fate Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fate Therapeutics?

The current dividend yield of Fate Therapeutics is .

When does Fate Therapeutics pay dividends?

Fate Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fate Therapeutics?

Fate Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Fate Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fate Therapeutics located?

Fate Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fate Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fate Therapeutics from 6/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.

When did Fate Therapeutics pay the last dividend?

The last dividend was paid out on 6/29/2024.

What was the dividend of Fate Therapeutics in the year 2023?

In the year 2023, Fate Therapeutics distributed 0 USD as dividends.

In which currency does Fate Therapeutics pay out the dividend?

The dividends of Fate Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Fate Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Fate Therapeutics

Our stock analysis for Fate Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fate Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.